What often distinguishes the leaders in drug discovery and development from
the rest is the quality of their compound libraries and the ease of access
that they have to the information within those libraries. The screening of
natural products can provide greater structural diversity than standard sy
nthetic chemistry and offers significant opportunities for finding novel lo
w molecular weight lead compounds. However, which strategy is the best for
natural-product-based drug discovery? Two well established but relatively t
ime consuming approaches are the screening of crude extracts and pre-fracti
onated extracts. This case study describes a third, pure-compound-screening
approach, and discusses its benefits and pitfalls.